Botanix Pharmaceuticals Limited (ASX:BOT)
0.0540
0.00 (0.00%)
Mar 10, 2026, 10:52 AM AEST
Botanix Pharmaceuticals Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Net Income | -88.7 | -86.4 | -13.87 | -9.15 | -13.17 | -3.33 | Upgrade
|
| Depreciation & Amortization | 2.33 | 2.26 | 0.07 | 0.11 | 0.14 | 0.09 | Upgrade
|
| Other Amortization | 5.11 | 5.11 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 20.52 | 20.52 | 4.39 | 1.52 | 0.33 | 0.57 | Upgrade
|
| Other Operating Activities | 2.59 | 0.06 | - | -0 | - | - | Upgrade
|
| Change in Accounts Receivable | -4.16 | -4.16 | -2.34 | -0.41 | -0.1 | 0.09 | Upgrade
|
| Change in Inventory | -26.87 | -26.87 | 1.68 | -0.1 | -3.04 | - | Upgrade
|
| Change in Accounts Payable | 10.88 | 10.88 | 1.94 | -4.04 | 4.65 | -0.38 | Upgrade
|
| Operating Cash Flow | -78.29 | -78.58 | -8.13 | -12.07 | -11.18 | -2.97 | Upgrade
|
| Capital Expenditures | -0.2 | -0.29 | -0.11 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -0.76 | -17.89 | -7.05 | -2.91 | - | Upgrade
|
| Other Investing Activities | -0.44 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | -0.64 | -1.05 | -18 | -7.05 | -2.92 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | 28.4 | - | 1.85 | - | - | Upgrade
|
| Total Debt Issued | 28.4 | 28.4 | - | 1.85 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -1.85 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.19 | - | -0.12 | -0.15 | -0.13 | Upgrade
|
| Total Debt Repaid | -0.34 | -0.19 | - | -1.97 | -0.15 | -0.13 | Upgrade
|
| Net Debt Issued (Repaid) | 28.06 | 28.2 | - | -0.12 | -0.15 | -0.13 | Upgrade
|
| Issuance of Common Stock | 40.02 | 40.46 | 100.85 | 23.59 | - | - | Upgrade
|
| Other Financing Activities | -5.68 | -3.31 | -5.76 | -1.44 | - | - | Upgrade
|
| Financing Cash Flow | 62.4 | 65.36 | 95.1 | 22.03 | -0.15 | -0.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.29 | -0.06 | 0.09 | 0.06 | -0.01 | 0.01 | Upgrade
|
| Net Cash Flow | -16.82 | -14.34 | 69.06 | 2.96 | -14.27 | -3.09 | Upgrade
|
| Free Cash Flow | -78.49 | -78.87 | -8.24 | -12.08 | -11.19 | -2.98 | Upgrade
|
| Free Cash Flow Margin | -358.13% | -1362.39% | -398.17% | -320.27% | -406.24% | -43.21% | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.04 | -0.01 | -0.01 | -0.01 | -0.00 | Upgrade
|
| Cash Interest Paid | 1.34 | 0.05 | - | 0.08 | 0.04 | 0.06 | Upgrade
|
| Cash Income Tax Paid | - | -1.5 | - | -3.67 | -2.75 | -6.88 | Upgrade
|
| Levered Free Cash Flow | -32.33 | -38.58 | -20.3 | -15.57 | -9 | -1.78 | Upgrade
|
| Unlevered Free Cash Flow | -33.11 | -40.34 | -20.3 | -15.52 | -8.97 | -1.74 | Upgrade
|
| Change in Working Capital | -20.14 | -20.14 | 1.28 | -4.55 | 1.51 | -0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.